Anatomical and functional MR imaging to define tumoral boundaries and characterize lesions in neuro-oncology.
Brain Neoplasms
/ diagnostic imaging
Contrast Media
/ administration & dosage
Disease Progression
Glioblastoma
/ diagnostic imaging
Glioma
/ diagnostic imaging
Humans
Magnetic Resonance Imaging
/ methods
Magnetic Resonance Spectroscopy
/ methods
Neoplasm Grading
Neuroimaging
/ methods
Subtraction Technique
Treatment Outcome
Brain tumours
Dose painting
IRM de perfusion
Neuro-imagerie
Neuroimaging
Perfusion MRI
Proton magnetic resonance spectroscopy
Radiomics
Radiomique
Segmentation tumorale
Spectroscopie magnétique
Tumeurs cérébrales
Tumour segmentation
Journal
Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique
ISSN: 1769-6658
Titre abrégé: Cancer Radiother
Pays: France
ID NLM: 9711272
Informations de publication
Date de publication:
Aug 2020
Aug 2020
Historique:
received:
11
12
2019
accepted:
04
03
2020
pubmed:
13
4
2020
medline:
23
7
2020
entrez:
13
4
2020
Statut:
ppublish
Résumé
Neuroimaging and especially MRI has emerged as a necessary imaging modality to detect, measure, characterize and monitor brain tumours. Advanced MRI sequences such as perfusion MRI, diffusion MRI and spectroscopy as well as new post-processing techniques such as automatic segmentation of tumours and radiomics play a crucial role in characterization and follow up of brain tumours. The purpose of this review is to provide an overview on anatomical and functional MRI use for brain tumours boundaries determination and tumour characterization in the specific context of radiotherapy. The usefulness of anatomical and functional MRI on particular challenges posed by radiotherapy such as pseudo progression and pseudo esponse and new treatment strategies such as dose painting is also described.
Identifiants
pubmed: 32278653
pii: S1278-3218(20)30069-X
doi: 10.1016/j.canrad.2020.03.005
pii:
doi:
Substances chimiques
Contrast Media
0
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
453-462Informations de copyright
Copyright © 2020 Société française de radiothérapie oncologique (SFRO). Published by Elsevier Masson SAS. All rights reserved.